https://upalpha.com/biotech/biomarin-presents-new-data-on-the-effect-of-long-term-treatment-with-voxzogo-vosoritide-on-arm-span-bone-health-and-growth-in-children-with-achondroplasia-at-the-pediatric-endocrine-society/
BioMarin Presents New Data on the Effect of Long-Term Treatment with VOXZOGO® (vosoritide) on Arm...
May 3, 2026 - VOXZOGO is the only approved treatment for children with achondroplasia starting at birth, with over 10 years of clinical research demonstrating the long-term
on thelong termbiomarinpresentsnew
https://www.onhealthcare.tech/p/the-peptide-split-how-glp-1s-lutathera
The Peptide Split: How GLP-1s, Lutathera, Vosoritide, and Peptide Cancer Vaccines Are Quietly...
May 8, 2026 - Quick Links: Knowledge Base, Podcast, and Social
cancer vaccinespeptidesplitglplutathera
https://pure.johnshopkins.edu/en/publications/long-term-vosoritide-treatment-sustains-bone-growth-and-may-enhan/
Long-term vosoritide treatment sustains bone growth and may enhance wellbeing in children with...
long termbone growthin childrenvosoritidetreatment